FILE PHOTO: Staff member handles AstraZeneca COVID-19 vaccines in storage at Region Hovedstaden's Vaccine Center, Copenhagen, Denmark February 11, 2021. Ritzau Scanpix/Liselotte Sabroe via REUTERS
COPENHAGEN/OSLO/STOCKHOLM (Reuters) - Denmark, Sweden and Norway said on Friday they needed more time to decide whether to use AstraZeneca's COVID-19 vaccine even though the EU drug watchdog said the benefits outweighed the risks, prompting several countries to resume its use.
"We need time to get to the bottom of this," Soren Brostrom, head of the Danish Health Authority, told reporters on Friday.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
